NOS3 and liver disorder: Clinical studies conducted so far have revealed an increase in total NO in ESLD, a positive correlation with markers of inflammation and clinical signs of portal hypertension [35], and an increased release of NO in the splanchnic circulation despite decreased activity of eNOS in the cirrhotic liver [36].